Answers are grounded in this paper and cite their sources.
The aim of the study was to study the involvement of monocyte chemoattractant protein-1 in the development of the pathological process in rats with induced chronic colitis and to assess the effectiveness of correcting this condition with cerium dioxide nanoparticles. In rats with chronic colitis, the content of monocyte-chemokine protein-1 increased, compared with the determined indicators of the intact group. This may indicate the involvement of the studied cytokine in the development of the pathological process in the intestines of experimental animals. After the therapy with cerium dioxide nanoparticles, a decrease in the content of monocyte-chemoattractant protein in the blood serum was observed compared to the indicator obtained before the correction, however, this indicator did not return to the values in the control group.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: